Select Publications
Journal articles
, 2024, 'Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis', SCHIZOPHRENIA BULLETIN, http://dx.doi.org/10.1093/schbul/sbae169
, 2024, 'Drug dependence and prescribing ketamine for treatment-resistant depression in Australia and New Zealand', Australian and New Zealand Journal of Psychiatry, 58, pp. 831 - 838, http://dx.doi.org/10.1177/00048674241242315
, 2024, 'Facilitating routine data collection to improve clinical quality and research in Interventional Psychiatry: The CARE Network', Australian and New Zealand Journal of Psychiatry, 58, pp. 738 - 741, http://dx.doi.org/10.1177/00048674241266057
, 2024, 'Factors associated with electroconvulsive therapy treatment for adults with serious psychiatric conditions in Australia', Australian and New Zealand Journal of Psychiatry, 58, pp. 809 - 820, http://dx.doi.org/10.1177/00048674241266067
, 2024, 'Clinical Outcomes of Electroconvulsive Therapy (ECT) for Depression in Older Old People Relative to Other Age Groups Across the Adult Life Span: A CARE Network Study', International Journal of Geriatric Psychiatry, 39, http://dx.doi.org/10.1002/gps.6133
, 2024, 'Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUM', British Journal of Psychiatry the Journal of Mental Science, 225, pp. 349, http://dx.doi.org/10.1192/bjp.2024.189
, 2024, 'Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of repetitive transcranial magnetic stimulation', Australian and New Zealand Journal of Psychiatry, 58, pp. 641 - 655, http://dx.doi.org/10.1177/00048674241249846
, 2024, 'Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial', Nature Medicine, 30, pp. 2004 - 2009, http://dx.doi.org/10.1038/s41591-024-03063-x
, 2024, 'Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)', Journal of Affective Disorders, 352, pp. 163 - 170, http://dx.doi.org/10.1016/j.jad.2024.02.052
, 2024, 'Individualised Transcranial Magnetic Stimulation Targeting of the Left Dorsolateral Prefrontal Cortex for Enhancing Cognition: A Randomised Controlled Trial', Brain Sciences, 14, pp. 299, http://dx.doi.org/10.3390/brainsci14040299
, 2024, 'Cognitive Effects Following Offline High-Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) in Healthy Populations: A Systematic Review and Meta-Analysis', Neuropsychology Review, 34, pp. 250 - 276, http://dx.doi.org/10.1007/s11065-023-09580-9
, 2024, 'Electroconvulsive Therapy Credentialing for Psychiatrists-Review of Required Standards Across States and Territories in Australia', Journal of ECT, 40, pp. 10 - 14, http://dx.doi.org/10.1097/YCT.0000000000000955
, 2024, 'Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality', Neuroscience and Biobehavioral Reviews, 158, http://dx.doi.org/10.1016/j.neubiorev.2024.105570
, 2024, 'Ensuring the affordable becomes accessible–lessons from ketamine, a new treatment for severe depression', Australian and New Zealand Journal of Psychiatry, 58, pp. 109 - 116, http://dx.doi.org/10.1177/00048674231203898
, 2024, 'Association of blood-based inflammatory proteins with MADRS change after repeated subcutaneous ketamine injections in treatment-resistant depressive patients', Neuroscience Applied, 3, pp. 104280 - 104280, http://dx.doi.org/10.1016/j.nsa.2024.104280
, 2024, 'Expecting the unexpected: DNA methylation changes after a single dose of ketamine?', Neuroscience Applied, 3, pp. 104353 - 104353, http://dx.doi.org/10.1016/j.nsa.2024.104353
, 2024, 'Longitudinal analysis of differentially expressed genes in pharmacologically treated patients with treatment-resistant depression', Neuroscience Applied, 3, pp. 104287 - 104287, http://dx.doi.org/10.1016/j.nsa.2024.104287
, 2024, 'Pharmacogenomic interactions of ketamine and BDNF genetic variants in patients with treatment-resistant depression', Neuroscience Applied, 3, pp. 105043 - 105043, http://dx.doi.org/10.1016/j.nsa.2024.105043
, 2023, 'Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial', British Journal of Psychiatry, 223, pp. 533 - 541, http://dx.doi.org/10.1192/bjp.2023.79
, 2023, 'Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Combined with Psychological Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials', Brain Sciences, 13, pp. 1665, http://dx.doi.org/10.3390/brainsci13121665
, 2023, 'Randomised controlled trial of neurostimulation for symptoms of anorexia nervosa (TRENA study): study protocol', Journal of Eating Disorders, 11, pp. 218, http://dx.doi.org/10.1186/s40337-023-00940-7
, 2023, 'The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder', Trials, 24, pp. 686, http://dx.doi.org/10.1186/s13063-023-07631-3
, 2023, 'Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study', Plos One, 18, pp. e0290876, http://dx.doi.org/10.1371/journal.pone.0290876
, 2023, 'The association between outpatient continuation/maintenance electroconvulsive therapy, readmission risk and total direct cost in patients with depressive, bipolar and psychotic disorders: A naturalistic retrospective cohort study', Journal of Affective Disorders, 338, pp. 289 - 298, http://dx.doi.org/10.1016/j.jad.2023.06.016
, 2023, 'Impact on Electroconvulsive Therapy Services, Including Patient Relapse and Death, During the COVID-19 Pandemic: Quantitative Results From a Multinational Survey', Journal of ECT, 39, pp. 179 - 184, http://dx.doi.org/10.1097/YCT.0000000000000908
, 2023, 'Prescribing electroconvulsive therapy for depression: Not as simple as it used to be', Australian and New Zealand Journal of Psychiatry, 57, pp. 1202 - 1207, http://dx.doi.org/10.1177/00048674231183368
, 2023, 'Ketamine for the treatment of major depression: a systematic review and meta-analysis', Eclinicalmedicine, 62, pp. 102127, http://dx.doi.org/10.1016/j.eclinm.2023.102127
, 2023, 'Time-course of the tDCS antidepressant effect: An individual participant data meta-analysis', Progress in Neuro Psychopharmacology and Biological Psychiatry, 125, pp. 110752, http://dx.doi.org/10.1016/j.pnpbp.2023.110752
, 2023, 'A systematic review of the print media representation of ketamine treatments for psychiatric disorders', Bjpsych Open, 9, pp. e104, http://dx.doi.org/10.1192/bjo.2023.75
, 2023, 'Transcranial Direct Current Stimulation Modulates Working Memory Maintenance Processes in Healthy Individuals', Journal of Cognitive Neuroscience, 35, pp. 468 - 484, http://dx.doi.org/10.1162/jocn_a_01957
, 2023, 'The effect of tDCS electrode montage on attention and working memory', Neuropsychologia, 179, pp. 108462, http://dx.doi.org/10.1016/j.neuropsychologia.2022.10846t2
, 2023, 'Change in Negative Affective Bias following a Single Ketamine Treatment for Treatment-Resistant Depression', Depression and Anxiety, 2023, pp. 3371272 - 8, http://dx.doi.org/10.1155/2023/3371272
, 2023, 'A Nationwide Survey of Continuous and Maintenance ECT in Japan', Brain Stimulation, 16, pp. 349, http://dx.doi.org/10.1016/j.brs.2023.01.670
, 2023, 'Approach to Establish a Foundation for Japan National Registry Research in ECT', Brain Stimulation, 16, pp. 349, http://dx.doi.org/10.1016/j.brs.2023.01.669
, 2023, 'Cognitive enhancement following offline high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) in healthy populations: A systematic review and meta-analysis', Brain Stimulation, 16, pp. 258, http://dx.doi.org/10.1016/j.brs.2023.01.422
, 2023, 'Effects of Anesthesia-ECT Time Interval on Seizure Quality and Clinical Outcome: An Interim Report on a Prospective Randomized Trial of AETI 150 sec vs. 240 sec', Brain Stimulation, 16, pp. 348, http://dx.doi.org/10.1016/j.brs.2023.01.667
, 2023, 'Impacts on electroconvulsive therapy (ECT) services, including patient relapse and death, during the COVID-19 pandemic: Mixed methods results from a multi-national survey', Brain Stimulation, 16, pp. 7, http://dx.doi.org/10.1016/j.brs.2023.03.032
, 2022, 'Comparative efficacy, cognitive effects and acceptability of electroconvulsive therapies for the treatment of depression: Protocol for a systematic review and network meta-analysis', BMJ Open, 12, pp. e068313, http://dx.doi.org/10.1136/bmjopen-2022-068313
, 2022, 'Neuromodulatory effects of theta burst stimulation to the prefrontal cortex', Scientific Data, 9, pp. 717, http://dx.doi.org/10.1038/s41597-022-01820-6
, 2022, 'Strategies from A Multi-National Sample of Electroconvulsive Therapy (ECT) Services: Managing Anesthesia for ECT during the COVID-19 Pandemic', Psychiatry International, 3, pp. 320 - 331, http://dx.doi.org/10.3390/psychiatryint3040026
, 2022, 'Transcranial direct current stimulation effects in late life depression: A meta-analysis of individual participant data', Journal of Affective Disorders Reports, 10, pp. 100407, http://dx.doi.org/10.1016/j.jadr.2022.100407
, 2022, 'Digitalized transcranial electrical stimulation: A consensus statement', Clinical Neurophysiology, 143, pp. 154 - 165, http://dx.doi.org/10.1016/j.clinph.2022.08.018
, 2022, 'The utility of the Sydney Melancholia Prototype Index (SMPI) for predicting response to electroconvulsive therapy in depression: A CARE Network study', Journal of Psychiatric Research, 155, pp. 180 - 185, http://dx.doi.org/10.1016/j.jpsychires.2022.08.011
, 2022, '“ECT should never stop”: Exploring the experiences and recommendations of ECT clinical directors and anesthetists about ECT during the COVID-19 pandemic', Frontiers in Psychiatry, 13, pp. 946748, http://dx.doi.org/10.3389/fpsyt.2022.946748
, 2022, 'Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment-Refractory Depression', Clinical Pharmacology and Therapeutics, 112, pp. 720 - 729, http://dx.doi.org/10.1002/cpt.2640
, 2022, 'Reliability of transcranial magnetic stimulation evoked potentials to detect the effects of theta-burst stimulation of the prefrontal cortex', Neuroimage Reports, 2, pp. 100115, http://dx.doi.org/10.1016/j.ynirp.2022.100115
, 2022, 'Esketamine A nasal spray for treatment-resistant depression', Medicine Today, 23, pp. 68 - 70
, 2022, 'Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again', Australian and New Zealand Journal of Psychiatry, 56, pp. 905 - 909, http://dx.doi.org/10.1177/00048674211068788
, 2022, 'Further Evidence Supporting the Utility of ECT for People With Cognitive Impairment', American Journal of Geriatric Psychiatry, 30, pp. 799 - 800, http://dx.doi.org/10.1016/j.jagp.2022.01.004
, 2022, 'The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry', Journal of Affective Disorders, 308, pp. 44 - 46, http://dx.doi.org/10.1016/j.jad.2022.04.020